Description
Zykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic non-small cell lung cancer. Each tablet contains 150 mg of ceritinib. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Ceritinib | HTML | Access the FDA dataset for Ceritinib — ANDA 211225 submitted by Mylan Institutional LLC | Open resource |